Metraipolis › archive › dc_89ee8f14409b
Vedolizumab Dose Escalation Resolves Immune Checkpoint Inhibitor-Induced Colitis in Two Patients — Europe PMC PMID:41036260
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41036260
- DOI
- 10.1155/crom/7637337
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T19:26:46.638Z
- SHA-256 of the archived text
2e6350dd697b28f267c04e0291fef319ca705ac95f48f65bf4ac44ec2f387f5f- Stable URL of this page
https://metraipolis.com/documento/dc_89ee8f14409b
How to cite
Vedolizumab Dose Escalation Resolves Immune Checkpoint Inhibitor-Induced Colitis in Two Patients — Europe PMC PMID:41036260 — Europe PMC (en), https://europepmc.org/article/MED/41036260 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_89ee8f14409b (Metraipolis archive dc_89ee8f14409b, sha256 2e6350dd697b28f267c04e0291fef319ca705ac95f48f65bf4ac44ec2f387f5f)
BibTeX
@misc{dc89ee8f14409b,
title = {Vedolizumab Dose Escalation Resolves Immune Checkpoint Inhibitor-Induced Colitis in Two Patients — Europe PMC PMID:41036260},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41036260},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_89ee8f14409b; sha256 2e6350dd697b28f267c04e0291fef319ca705ac95f48f65bf4ac44ec2f387f5f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41036260. Agents can read the archived copy with the MCP tool read_document.